QCI Asset Management’s Insmed INSM Stock Holding History

QCI Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,230	Closed	-$55K	–	578
2017 Q2	$55K	Buy	+3,230	New	+$55.2K	0.01%	214

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

QCI Asset Management's INSM Position: Q3 2017 in Review

QCI Asset Management sold out of Insmed (INSM) in Q3 2017, closing a stake of 3,230 shares — an estimated $55K sold.

QCI Asset Management first reported a position in INSM in Q2 2017 and held it in 1 quarter. The position peaked at $55K in Q2 2017. 146 funds tracked by Wall St. Rank hold INSM as of Q3 2017.

QCI Asset Management reported no remaining Insmed position as of Q3 2017 after selling out during the quarter.
QCI Asset Management sold 3,230 Insmed shares in Q3 2017, an estimated $55K.
QCI Asset Management first reported a position in Insmed in Q2 2017 and held it in 1 quarter.
QCI Asset Management's Insmed position peaked at $55K in Q2 2017.
146 funds tracked by Wall St. Rank held Insmed as of Q3 2017.

Based on QCI Asset Management's 13F filing for Q3 2017, filed 6 Nov 2017.